Next, HEK293-TLR4 cells were treated with LPS and NF-B activation was measured. immune responses. Sepsis is definitely caused by hyper-responsiveness of the immune system, in which the mortality rate is as high as 50% (1). In septic conditions, large amount of pro-inflammatory cytokines is definitely produced rapidly. Therefore, the early innate response of the immune system to pathogens takes on a critical part in septic conditions. Toll-like receptors (TLRs) are important pattern acknowledgement receptors (PRRs) that participate in the innate immune response. TLR4, in conjunction with CD14, functions as the receptor for lipopolysaccharide (LPS), a component of Gram-negative bacteria cell walls (2). TLR2 PR22 recognizes peptidoglycan and lipoteichoic acid (LTA) in Gram-positive bacteria cell walls (3). Activation of TLR2 or TLR4 through binding of their ligands prospects to NF-B activation and transcription of many genes, including standard pro-inflammatory cytokines such as tumor necrosis element- (TNF-), interleukin-1 (IL-1), and IL-6 as well as several chemokines that recruit leukocytes into the site of swelling (4,5). CKD-712 has been developed as an anti-inflammatory agent focusing on sepsis. CKD-712 is definitely a higenamine derivative (1-alpha-naphthylmethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline), also referred to as YS 49. It has been demonstrated that CKD-712 reduced NO production in macrophage cells and improved survival rates in mice after LPS treatment (6,7). Furthermore inhibition of the Janus triggered kinase (JAK)-2/transmission transducer and activators of transcription (STAT)-1 pathway by CKD-712 has been reported to decrease levels of iNOS, cyclooxygenase-2, and hemeoxygenase-1 in macrophage cells (8). More recently, CKD-712 AS601245 was found to suppress the secretion of high-mobility group package 1 (HMGB-1) via inhibition of phosphatidylinositol 3 (PI3K)-protein kinase C (PKC) signaling after LTA or LPS activation in macrophage cells (9). With this study we attempted to determine which signaling pathway is definitely affected by CKD-712 after TLR4 activation, since TLR4 is the major PRRs responsible in development of sepsis. HEK293-TLR4 cells (kindly provided by Professor Douglas T. Golenbock, Massachusetts University or college, USA) were cultured in 10% fetal bovine serum-RPMI1640 medium. HEK293-TLR4 cells communicate MD2 and CD14 as well. CKD-712 was kindly provided by ChongKunDang Pharm, Cheonan. LPS was purchased from Sigma-Aldrich, St. Louis, MI, USA. To assess cell viability after treatment of CKD-712, cells were reacted with 5 mg/ml of tetrazolium salt (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, MTT) (Sigma-Aldrich). After 3 hrs of incubation (37, 5% CO2) the medium comprising MTT was eliminated and 200l of DMSO was added into the well and the absorbance was measured at 540 nm. For the luciferase assay. 2105cells/well were seeded in 12-well plates and cultured for 2 days. NF-B promoter and pCMV -gal vector were co-transfected over night, AS601245 and CKD-712 was pre-treated before LPS treatment. LPS was treated for 6 hrs. Luciferase activity was measured by a Luciferase Reporter Assay System (Promega, Madison, WI, USA) and -galactosidase activity was measured with O-nitrophenyl–D-galactopyranoside (Sigma-Aldrich), as the substrate. Luciferase activity was normalized for transfection effectiveness with the -galactosidase activity. Western blotting was carried out using anti-TLR4, anti-ERK, anti-p38, anti-JNK, anti-IRF3 or anti-Akt antibodies as well as control antibodies. All the antibodies were purchased from Cell Signaling Technology (Beverly, MA, USA). First, we identified the optimal concentration of CKD-712 in HEK293-TLR4 cells. When treated with CKD-712 for 24 hrs the cell viability was 50% at 100M and 40% at 200M (Fig. 1A). Next, HEK293-TLR4 cells were treated with LPS and NF-B activation was measured. CKD-712 was pre-treated 1 hr before activation of AS601245 LPS. We found that 50M of CKD-712 inhibited NF-B activation in TLR4 signaling. When treated with 50M of CKD-712, NF-B activation decreased to less than 100,000 RIU (25 ng/ml of LPS) and 200,000 RIU (50 ng/ml of LPS) when compared to 200,000 RIU and 500,000 RIU, respectively in control organizations (Fig. 1B). == Number 1. == Effect of CKD-712 on TLR4 signaling. (A) To assess CKD-712 toxicity HEK293-TLR4 cells (2105) were cultured with CKD-712.